C-Myc: Difference between revisions
Michal Harel (talk | contribs) No edit summary |
Michal Harel (talk | contribs) No edit summary |
||
| (6 intermediate revisions by 2 users not shown) | |||
| Line 13: | Line 13: | ||
[[Proteins involved in cancer]]<br /> | [[Proteins involved in cancer]]<br /> | ||
[[Oncogenes & Tumor Suppressor Genes]]. | [[Oncogenes & Tumor Suppressor Genes]]. | ||
[[Category:Topic Page]] | |||
| Line 45: | Line 46: | ||
[[2a93]] – Cmyc-Max leucine zipper – synthetic – NMR<br /> | [[2a93]] – Cmyc-Max leucine zipper – synthetic – NMR<br /> | ||
[[2ap2]] – sCmyc + antibody<br /> | [[2ap2]] – sCmyc + antibody<br /> | ||
[[1nkp]] – hCmyc + hMax + DNA | [[5i4z]] - hCmyc bHLHZ domain residues 348-439 - human<br /> | ||
[[7c36]] - hCmyc residues 62-223 - NMR<br /> | |||
[[5i50]] - hCmyc bHLHZ domain + DNA<br /> | |||
[[6g6j]], [[6g6k]], [[6g6l]] – hCmyc + hMax<br /> | |||
[[1nkp]] – hCmyc + hMax + DNA <br /> | |||
[[1mv0]] – hCmyc residues 55-68 + box-dependent-interacting protein residues 513-593 - NMR | [[1mv0]] – hCmyc residues 55-68 + box-dependent-interacting protein residues 513-593 - NMR | ||
[[8ots]], [[8ott]] - hCmyc bHLHZ domain 368-420 complx with nucleosome – Cryo EM | |||
==Additional Resources== | ==Additional Resources== | ||